Yıl: 2022 Cilt: 7 Sayı: 2 Sayfa Aralığı: 475 - 481 Metin Dili: İngilizce DOI: 10.30728/boron.1076636 İndeks Tarihi: 28-11-2022

In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties

Öz:
Antioxidant, antimicrobial and antibiofilm activities of potassium metaborate (KBO2) was investigated within the present study. Antioxidant capacity of potassium metaborate was determined by β-carotene bleaching (BCB) assay and hydroxyl radical scavenging activity. Potassium metaborate was evaluated for its antimicrobial effects against selected Gram-positive bacteria, Gram-negative bacteria and a yeast via broth dilution method. The inhibition capability of potassium metaborate on the microbial biofilm formation of tested microorganisms was measured by microplate biofilm method using MTT (3- [4, 5- dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium-bromide). Biofilm inhibition capacity of potassium metaborate was also observed by Scanning Electron Microscope (SEM). Potassium metaborate was found to have the ability to scavenge hydroxyl radicals with an inhibition rate of 71.13% at 100 mM concentration. Antioxidant activity of potassium metaborate as determined by BCB assay gave higher result with an inhibition rate of 86.96% at the same concentration. According to the MIC (minimum inhibition concentration) values, the potassium metaborate inhibited the growth of C. albicans, S. aureus and E. coli at 62.5 mM concentrations while it was 31.25 mM for B. subtilis and 125 mM for P. aeruginosa. The highest antibiofilm activity was determined at the MIC of potassium metaborate with the reduction rate of 90.18% against C. albicans. It was concluded that, potassium metaborate have strong biological activities and can be effectively used for biomedical and environmental solutions.
Anahtar Kelime: boron potassium metaborate antioxidant antimicrobial antibiofilm

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1] Ciani, L. & Ristori, S. (2012). Boron as a platform for new drug design. Expert Opinion on Drug Discovery . 7(11), 1017-1027.
  • [2] Anovitz, L. M., & Grew, E. S. (1996). An introduction in mineralogy, petrology and geochemistry of boron. Re- views in Mineralogy and Geochemistry, 33(1), 1-40.
  • [3] Shah, F. U., Glavatskih, S. & Antzutkin, O. N. (2013). Bo- ron in tribology: From borates to ionic liquids, Tribology Letters, 51, 281-301.
  • [4] Nielsen, F. H. (1988). Boron-an overlooked element of potential nutritional importance, Nutrition Today, 23(1), 4-7.
  • [5] Devirian, T. A., & Volpe, S. L. (2003). The physiological effects of dietary boron, Critical Reviews in Food Science and Nutrition, 43(2), 219-231.
  • [6] Soriano-Ursúa, M. A. (2019). Chemico-biological activity and medicinal chemistry of boron-containing compounds. Current Medicinal Chemistry, 26(26), 5003-5004.
  • [7] Murray, F. J. (1998). A comparative review of the phar- macokinetics of boric acid in rodents and humans, Bio- logical Trace Element Research, 66, 331-341.
  • [8] Ince, S., Kucukkurt, I., Demirel, H. H., Acaroz, D. A., Ak- bel, E., & Cigerci I. H. (2014). Protective effects of bo- ron on cyclophosphamide induced lipid peroxidation and genotoxicity in rats, Chemosphere, 108, 197-204.
  • [9] Yilmaz, M. T. (2012). Minimum inhibitory and minimum bactericidal concentrations of boron compounds against several bacterial strains, Turkish Journal of Medical Sci- ences, 42(Sup. 2), 1423-1429.
  • [10] Türkez, H., Geyikoǧlu, F., Tatar, A., Keleş, S., & Özkan, A. (2007). Effects of some boron compounds on pe- ripheral human blood, Zeitschrift für Naturforschung C, 62(11-12), 889-896.
  • [11] Yenmez, N. (2009). The importance of boron minerals in Turkey as a strategic mine. Journal of Geography , 0(19), 59-94..
  • [12] Zhang, C. H., Yu, Y., Liang, Y. Z., & Chen, X. Q. (2015). Purification, partial characterization and antioxidant ac- tivity of polysaccharides from Glycyrrhiza uralensis, In- ternational Journal of Biolological Macromolecules, 79, 681-686.
  • [13] Rauter, A. P., Dias, C., Martins, A., Branco, I., Neng, N. R., Nogueira, J. M., & Waltho, J. P. (2012). Non-toxic Salvia sclareoides Brot. extracts as a source of func- tional food ingredients: Phenolic profile, antioxidant activity and prion binding properties, Food Chemistry , 132(4), 1930-1935.
  • [14] Clinical and Laboratory Standards Institute (CLSI) (2006). Performance standards for antimicrobial sus- ceptibility testing, Sixteenth Informational Supplement. Document M100-S16, Wayne, PA.
  • [15] Walencka, E., Sadowska, B., Rozalska, S., Hryniewicz, W., & Rózalska, B. (2005). Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradica- tion, Polish Journal of Microbiology, 54(3), 191-200.
  • [16] Baygar, T., Ugur, A., Sarac, N., Balci, U., & Ergun, G. (2018). Functional denture soft liner with antimicrobial and antibiofilm properties, Journal of Dental Sciences, 13(3), 213-219.
  • [17] Ince, S., Kucukkurt, I., Cigerci, I. H., Fidan, A. F., & Ery- avuz, A. (2010). The effects of dietary boric acid and borax supplementation on lipid peroxidation, antioxi- dant activity, and DNA damage in rats, Journal of Trace Elements in Medicine and Biology, 24(3), 161-164.
  • [18] Ince, S., Keles, H., Erdogan, M., Hazman, O., & Kucuk- kurt, I. (2012). Protective effect of boric acid against carbon tetrachloride-induced hepatotoxicity in mice, Drug and Chemical Toxicology, 35(3), 285-292.
  • [19] Soares, M. M. S. R., & Cury, A. E. (2001). In vitro activ- ity of antifungal and antiseptic agents against dermato- phyte isolates from patients with tinea pedis, Brazilian Journal of Microbiology, 32(2), 130-134.
  • [20] Benkovic, S. J., Baker, S. J., Alley, M. R. K., Woo, Y. H., Zhang, Y. K., Akama, T., & Shapiro, L. (2005). Iden- tification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH, Journal of Medicinal Chemistry, 48(23), 7468- 7476.
  • [21] De Seta, F., Schmidt, M., Vu, B., Essmann, M., & Lars- en, B. (2009). Antifungal mechanisms supporting boric acid therapy of Candida vaginitis, Journal of Antimicro- bial Chemotherapy, 63(2), 325-336.
  • [22] Sayın, Z., Ucan, U. S., & Sakmanoglu, A. (2016). An- tibacterial and antibiofilm effects of boron on different bacteria, Biological Trace Element Research, 173(1), 241-246.
  • [23] Argin, S., Gülerim, M., & Şahin, F. (2019). Development of antimicrobial gelatin films with boron derivatives, Turkish Journal of Biology, 43(1), 47-57.
  • [24] Baker, J., Ding, Z. C., Zhang, Y. K., Hernandez, V., & Xia, Y. (2009). Therapeutic potential of boron-contain- ing compounds, Future Medicinal Chemistry, 1(7), 1275-1288.
  • [25] Barth, R. F., Coderre, J. A., Vicente, M. G. H., & Blue, T. E. (2005). Boron neutron capture therapy of cancer: Current status and future prospects, Clinical Cancer Research, 11(11), 3987-4002.
  • [26] Henriksson, R., Capala, J., Michanek, A., Lindahl, S. A., Salford, L. G., Franzén, L., & Bergenheim, A. T. (2008). Boron neutron capture therapy (BNCT) for glioblasto- ma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA), Radiotherapy and Oncology, 88(2), 183-191.
  • [27] Dembitsky, V. M., & Srebnik, M. (2003). Synthesis and biological activity of r-aminoboronic acids. amine-car- boxyboranes and their derivatives, Tetrahedron, 59(5), 579-593.
  • [28] Baldock, C., de Boer, G. J., Rafferty, J. B., Stuitje, A. R.,& Rice, D. W. (1998). Mechanism of action of di- azaborines, Biochemical Pharmacology, 55(10), 1541- 1549.
  • [29] Surolia, N., RamachandraRao, S. P., & Surolia, A. (2002). Paradigm shifts in malaria parasite biochem- istry and anti-malarial chemotherapy, Bioessays, 24, 192-196.
  • [30] Jabbour, A., Steinberg, D., Dembitsky, V. M., Mous- saieff, A., Zaks, B., & Srebnik, M. (2004). Synthesis and evaluation of oxazaborolidines for antibacterial activity against Streptococcus mutans, Journal of Medicinal Chemistry, 47(10), 2409-2410.
  • [31] Sánchez-Gómez, S., Ferrer-Espada, R., Stewart, P. S., Pitts, B., Lohner, K., & de Tejada, G. M. (2015). Anti- microbial activity of synthetic cationic peptides and li- popeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and bio- films, BMC Microbiology, 15(1), 137.
  • [32] Mah, T. F., & O’Toole, G. A. (2001). Mechanisms of bio- film resistance to antimicrobial agents, Trends in Micro- biology, 9(1), 34-39.
  • [33] Mansour, T. S., Bradford, P. A., & Venkatesan, A. M. (2008). Recent developments in β-lactamases and in- hibitors, Annual Reports in Medicinal Chemistry, 43, 247-267.
  • [34] Hernandez, V., Crépin, T., Palencia, A., Cusack, S., Akama, T., Baker, S. J., ... & Plattner, J. J. (2013). Dis- covery of a novel class of boron-based antibacterials with activity against gram-negative bacteria, Antimicro- bial Agents and Chemotherapy, 57(3), 1394-1403.
  • [35] Chen, X., Schauder, S., Potier, N., Van Dorsselaer, A., & Pelczer, I. (2002). Structural identification of a bac- terial quorum-sensing signal containing boron, Nature, 415, 545-549.
  • [36] Lowery, C. A., Salzameda, N. T., Sawada, D., Kaufmann, G. F., & Janda, K. D. (2010). Medicinal chemistry as a conduit for the modulation of quorum sensing, Journal of Medicinal Chemistry, 53(21), 7467-7489. Baygar T. et al. / BORON 7(2), 475 - 481, 2022
  • [37] Ceylan, Ö., Saraç, N., Uğur, A., & Baygar, T. (2019) As- sessment of the anti-quorum sensing activity and cyto- toxicity of potassium metaborate, International Sympo- sium on Boron (p.1065), Türkiye.
APA BAYGAR T, Sarac N, Ceylan O, Ugur A, Boran R, Balcı U (2022). In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. , 475 - 481. 10.30728/boron.1076636
Chicago BAYGAR TUBA,Sarac Nurdan,Ceylan Ozgur,Ugur Aysel,Boran Rukiye,Balcı Uydu In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. (2022): 475 - 481. 10.30728/boron.1076636
MLA BAYGAR TUBA,Sarac Nurdan,Ceylan Ozgur,Ugur Aysel,Boran Rukiye,Balcı Uydu In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. , 2022, ss.475 - 481. 10.30728/boron.1076636
AMA BAYGAR T,Sarac N,Ceylan O,Ugur A,Boran R,Balcı U In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. . 2022; 475 - 481. 10.30728/boron.1076636
Vancouver BAYGAR T,Sarac N,Ceylan O,Ugur A,Boran R,Balcı U In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. . 2022; 475 - 481. 10.30728/boron.1076636
IEEE BAYGAR T,Sarac N,Ceylan O,Ugur A,Boran R,Balcı U "In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties." , ss.475 - 481, 2022. 10.30728/boron.1076636
ISNAD BAYGAR, TUBA vd. "In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties". (2022), 475-481. https://doi.org/10.30728/boron.1076636
APA BAYGAR T, Sarac N, Ceylan O, Ugur A, Boran R, Balcı U (2022). In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. BOR DERGİSİ, 7(2), 475 - 481. 10.30728/boron.1076636
Chicago BAYGAR TUBA,Sarac Nurdan,Ceylan Ozgur,Ugur Aysel,Boran Rukiye,Balcı Uydu In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. BOR DERGİSİ 7, no.2 (2022): 475 - 481. 10.30728/boron.1076636
MLA BAYGAR TUBA,Sarac Nurdan,Ceylan Ozgur,Ugur Aysel,Boran Rukiye,Balcı Uydu In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. BOR DERGİSİ, vol.7, no.2, 2022, ss.475 - 481. 10.30728/boron.1076636
AMA BAYGAR T,Sarac N,Ceylan O,Ugur A,Boran R,Balcı U In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. BOR DERGİSİ. 2022; 7(2): 475 - 481. 10.30728/boron.1076636
Vancouver BAYGAR T,Sarac N,Ceylan O,Ugur A,Boran R,Balcı U In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties. BOR DERGİSİ. 2022; 7(2): 475 - 481. 10.30728/boron.1076636
IEEE BAYGAR T,Sarac N,Ceylan O,Ugur A,Boran R,Balcı U "In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties." BOR DERGİSİ, 7, ss.475 - 481, 2022. 10.30728/boron.1076636
ISNAD BAYGAR, TUBA vd. "In vitro biological activities of potassium metaborate; antioxidative, antimicrobial and antibiofilm properties". BOR DERGİSİ 7/2 (2022), 475-481. https://doi.org/10.30728/boron.1076636